Composition for eliminating subcutaneous fat deposition and application of composition

A technology for subcutaneous fat and composition, applied in the field of compositions for eliminating subcutaneous fat deposition, can solve problems such as failure to provide a clear solution, complex prostaglandin pharmacology, loose skin, etc. Sedimentation, rosy skin effect

Active Publication Date: 2018-03-09
程辉
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most importantly, the use of prostaglandin F2α and its analogues may also lead to skin relaxation and pigmentation in the corresponding parts, which is contrary to the original intention of beauty treatment
For this

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for eliminating subcutaneous fat deposition and application of composition
  • Composition for eliminating subcutaneous fat deposition and application of composition
  • Composition for eliminating subcutaneous fat deposition and application of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062]

Embodiment 2

[0064]

Embodiment 3

[0066]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of weight loss and beautification, and particularly relates to a composition for eliminating subcutaneous fat deposition and application of the composition. The composition comprises prostaglandin F2 alpha (PGF2 alpha) receptor stimulants and skin care active components. A mass ratio of the prostaglandin F2 alpha receptor stimulants to the skin care active components in the composition is 0.1-10:1-100, and the preferable mass ratio of the prostaglandin F2 alpha receptor stimulants to the skin care active components is 0.1-1:1-100. The composition and the application have the advantages that the composition can be locally applied to skin surfaces, accordingly, effects of eliminating the subcutaneous fat deposition can be realized, and skin can be whitenedand tightened; the composition is convenient to use, high in safety and free of side effects.

Description

technical field [0001] The invention belongs to the field of weight loss and beauty, and in particular relates to a composition for eliminating subcutaneous fat deposition and application thereof. The composition contains prostaglandin F2α (PGF2α) receptor agonist and skin care active ingredients. Background technique [0002] A variety of treatments already exist to reduce fat deposition, such as targeted drugs that reduce total fat levels in tissues, lipase inhibitors, selective 5-HT2C receptor agonists and appetite suppressants, liposuction bariatric surgery and surgery Intervention to reduce food intake, etc. However, oral drugs may have potential side effects and drug resistance, and surgical treatment needs to invade the human body, which will cause trauma and be expensive. None of these existing methods and technologies can be well applied. [0003] Eye bags are caused by mild swelling or puffiness of the epidermis and subcutaneous tissue in the area under the eyes. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K45/06A61K31/5575A61K31/519A61P3/04A61P17/00A61K8/37A61K8/42A61K8/365A61K8/49A61K8/34A61K8/44A61Q19/00A61Q19/02A61K31/05A61K31/198
CPCA61K8/347A61K8/365A61K8/37A61K8/42A61K8/44A61K8/4953A61K31/05A61K31/198A61K31/519A61K31/5575A61K45/06A61Q19/005A61Q19/02A61K2300/00
Inventor 程辉
Owner 程辉
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products